Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × lazertinib × 30 days × Clear all

Phase

Phase 2 4 Phase 1 2 Phase 3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 76 Carboplatin 73 Specimen Handling 58 Cisplatin 58 Magnetic Resonance Spectroscopy 57 Paclitaxel 52 Gemcitabine 44 Docetaxel 38 Dexamethasone 34 Pemetrexed 31 Bevacizumab 31 Radiation 28 Oxaliplatin 27 Nivolumab 27 Cyclophosphamide 27 durvalumab 26 Doxorubicin 26 Fluorouracil 25 Radiotherapy 24 Leucovorin 24 Lenalidomide 23 atezolizumab 22 Capecitabine 21 130-nm albumin-bound paclitaxel 20 Rituximab 19 Letrozole 19 daratumumab 18 Taxes 18 venetoclax 17 Vincristine 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05388669 2026-04-13

PALOMA-3

Janssen Research & Development, LLC

Phase 3 Active not recruiting

418 enrolled 16 charts 1 FDA

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡